Literature DB >> 12944494

Targeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in mice.

Jing Jin Gu1, Amy K Tolin, Jugnu Jain, Hai Huang, Lalaine Santiago, Beverly S Mitchell.   

Abstract

Inosine 5'-monophosphate dehydrogenase (IMPDH) is the critical, rate-limiting enzyme in the de novo biosynthesis pathway for guanine nucleotides. Two separate isoenzymes, designated IMPDH types I and II, contribute to IMPDH activity. An additional pathway salvages guanine through the activity of hypoxanthine-guanine phosphoribosyltransferase (HPRT) to supply the cell with guanine nucleotides. In order to better understand the relative contributions of IMPDH types I and II and HPRT to normal biological function, a mouse deficient in IMPDH type I was generated by standard gene-targeting techniques and bred to mice deficient in HPRT or heterozygous for IMPDH type II. T-cell activation in response to anti-CD3 plus anti-CD28 antibodies was significantly impaired in both single- and double-knockout mice, whereas a more general inhibition of proliferation in response to other T- and B-cell mitogens was observed only in mice deficient in both enzymes. In addition, IMPDH type I(-/-) HPRT(-/0) splenocytes showed reduced interleukin-4 production and impaired cytolytic activity after antibody activation, indicating an important role for guanine salvage in supplementing the de novo synthesis of guanine nucleotides. We conclude that both IMPDH and HPRT activities contribute to normal T-lymphocyte activation and function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12944494      PMCID: PMC193693          DOI: 10.1128/MCB.23.18.6702-6712.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Advantages of mizoribine over azathioprine in combination therapy with cyclosporine for renal transplantation.

Authors:  K Mita; N Akiyama; T Nagao; H Sugimoto; S Inoue; T Osakabe; Y Nakayama; K Yokota; K Sato; H Uchida
Journal:  Transplant Proc       Date:  1990-08       Impact factor: 1.066

2.  A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation.

Authors:  Y Kokado; M Ishibashi; H Jiang; S Takahara; T Sonoda
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

3.  IMP dehydrogenase, an enzyme linked with proliferation and malignancy.

Authors:  R C Jackson; G Weber; H P Morris
Journal:  Nature       Date:  1975-07-24       Impact factor: 49.962

4.  Two distinct cDNAs for human IMP dehydrogenase.

Authors:  Y Natsumeda; S Ohno; H Kawasaki; Y Konno; G Weber; K Suzuki
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

5.  Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.

Authors:  J S Dayton; L A Turka; C B Thompson; B S Mitchell
Journal:  Mol Pharmacol       Date:  1992-04       Impact factor: 4.436

6.  Regulation of IMP dehydrogenase gene expression by its end products, guanine nucleotides.

Authors:  D A Glesne; F R Collart; E Huberman
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

7.  Increased inosine-5'-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines.

Authors:  F R Collart; C B Chubb; B L Mirkin; E Huberman
Journal:  Cancer Res       Date:  1992-10-15       Impact factor: 12.701

8.  Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion.

Authors:  E M Eugui; S J Almquist; C D Muller; A C Allison
Journal:  Scand J Immunol       Date:  1991-02       Impact factor: 3.487

9.  De novo guanylate synthesis in the commitment to replication in hepatoma 3924A cells.

Authors:  Y Natsumeda; T Ikegami; K Murayama; G Weber
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

10.  Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine.

Authors:  L A Turka; J Dayton; G Sinclair; C B Thompson; B S Mitchell
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

View more
  16 in total

1.  De novo GMP synthesis is required for axon guidance in Drosophila.

Authors:  Hong Long; Scott Cameron; Li Yu; Yong Rao
Journal:  Genetics       Date:  2005-12-01       Impact factor: 4.562

Review 2.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

3.  Why do mutations in the ubiquitously expressed housekeeping gene IMPDH1 cause retina-specific photoreceptor degeneration?

Authors:  Sara J Bowne; Qin Liu; Lori S Sullivan; Jingya Zhu; Catherine J Spellicy; Catherine Bowes Rickman; Eric A Pierce; Stephen P Daiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

4.  Phenotypic characterization of a large family with RP10 autosomal-dominant retinitis pigmentosa: an Asp226Asn mutation in the IMPDH1 gene.

Authors:  Petra Kozma; Dianna K Hughbanks-Wheaton; Kirsten G Locke; Garry E Fish; Anisa I Gire; Catherine J Spellicy; Lori S Sullivan; Sara J Bowne; Stephen P Daiger; David G Birch
Journal:  Am J Ophthalmol       Date:  2005-10-07       Impact factor: 5.258

Review 5.  GTP metabolic reprogramming by IMPDH2: unlocking cancer cells' fuelling mechanism.

Authors:  Satoshi Kofuji; Atsuo T Sasaki
Journal:  J Biochem       Date:  2020-10-01       Impact factor: 3.387

6.  Responses of Bovine Innate Immunity to Mycobacterium avium subsp. paratuberculosis Infection Revealed by Changes in Gene Expression and Levels of MicroRNA.

Authors:  Michela Malvisi; Fiorentina Palazzo; Nicola Morandi; Barbara Lazzari; John L Williams; Giulio Pagnacco; Giulietta Minozzi
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

7.  Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.

Authors:  Sara Bremer; Nils T Vethe; Helge Rootwelt; Pål F Jørgensen; Jean Stenstrøm; Hallvard Holdaas; Karsten Midtvedt; Stein Bergan
Journal:  J Transl Med       Date:  2009-07-27       Impact factor: 5.531

8.  CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics.

Authors:  Augustin Luna; Fathi Elloumi; Sudhir Varma; Yanghsin Wang; Vinodh N Rajapakse; Mirit I Aladjem; Jacques Robert; Chris Sander; Yves Pommier; William C Reinhold
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

9.  Bidirectional communication between oocytes and ovarian follicular somatic cells is required for meiotic arrest of mammalian oocytes.

Authors:  Karen Wigglesworth; Kyung-Bon Lee; Marilyn J O'Brien; Jia Peng; Martin M Matzuk; John J Eppig
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

10.  Neural crest requires Impdh2 for development of the enteric nervous system, great vessels, and craniofacial skeleton.

Authors:  Jonathan I Lake; Marina Avetisyan; Albert G Zimmermann; Robert O Heuckeroth
Journal:  Dev Biol       Date:  2015-11-10       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.